Clobazam and Icterus - a phase IV clinical study of FDA data

Summary:

Icterus is reported as a side effect among people who take Clobazam (clobazam), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Topiramate, and have Epilepsy.

The phase IV clinical study analyzes which people have Icterus when taking Clobazam. It is created by eHealthMe based on reports of 14,346 people who have side effects when taking Clobazam from the FDA, and is updated regularly.

What is Clobazam?

Clobazam has active ingredients of clobazam. eHealthMe is studying from 14,399 Clobazam users. Check the latest studies of Clobazam.

What is Icterus?

Icterus (yellowish pigmentation of the skin) is found to be associated with 2,024 drugs and 3,019 conditions by eHealthMe. Check the latest studies of Icterus.

On May, 14, 2026

14,346 people reported to have side effects when taking Clobazam.
Among them, 10 people (0.07%) have Icterus.

Among these 10 people:

How long have people been on Clobazam when they have Icterus? *

What is the gender of people who have Icterus when taking Clobazam? *

female: 60 %
male: 40 %

What is the age of people who have Icterus when taking Clobazam? *

What are other drugs people take besides Clobazam? *

Topiramate: 4 people, 40.00%
Lamictal: 3 people, 30.00%
Lacosamide: 2 people, 20.00%
Doxycycline: 2 people, 20.00%
Clotrimazole: 2 people, 20.00%
Azithromycin: 2 people, 20.00%
Fluconazole: 2 people, 20.00%
Melatonin: 2 people, 20.00%
Midazolam: 2 people, 20.00%
Midazolam Hydrochloride: 2 people, 20.00%

What are other side effects people have besides Icterus? *

Fever: 4 people, 40.00%
Inflammation: 3 people, 30.00%
C-Reactive Protein Increased: 3 people, 30.00%
Nausea And Vomiting: 3 people, 30.00%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 3 people, 30.00%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 30.00%
Blood Lactate Dehydrogenase Increased: 2 people, 20.00%
Gamma-Glutamyltransferase Increased: 2 people, 20.00%
Lymphocyte Count Increased: 2 people, 20.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 20.00%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 30.00%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 2 people, 20.00%
Hyperkinesia (higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs): 2 people, 20.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 10.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 10.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 10.00%
High Blood Pressure: 1 person, 10.00%
Depression: 1 person, 10.00%
Bladder Cancer: 1 person, 10.00%
Anaemia Postoperative: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clobazam and have Icterus?

- Check whether Icterus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clobazam:

Clobazam (14,399 reports)

Icterus treatments and more:

Icterus (33,621 reports)

Browse all side effects of Clobazam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Icterus:

Icterus (2,024 drugs)

Browse all the conditions that are associated with Icterus:

Icterus (3,019 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clobazam (the active ingredients of Clobazam) and Clobazam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.